Correlation Between Aba Chemicals and Innovative Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aba Chemicals and Innovative Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aba Chemicals and Innovative Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aba Chemicals Corp and Innovative Medical Management, you can compare the effects of market volatilities on Aba Chemicals and Innovative Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aba Chemicals with a short position of Innovative Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aba Chemicals and Innovative Medical.

Diversification Opportunities for Aba Chemicals and Innovative Medical

0.49
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Aba and Innovative is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Aba Chemicals Corp and Innovative Medical Management in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovative Medical and Aba Chemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aba Chemicals Corp are associated (or correlated) with Innovative Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovative Medical has no effect on the direction of Aba Chemicals i.e., Aba Chemicals and Innovative Medical go up and down completely randomly.

Pair Corralation between Aba Chemicals and Innovative Medical

Assuming the 90 days trading horizon Aba Chemicals Corp is expected to under-perform the Innovative Medical. But the stock apears to be less risky and, when comparing its historical volatility, Aba Chemicals Corp is 1.79 times less risky than Innovative Medical. The stock trades about -0.24 of its potential returns per unit of risk. The Innovative Medical Management is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest  968.00  in Innovative Medical Management on October 6, 2024 and sell it today you would lose (157.00) from holding Innovative Medical Management or give up 16.22% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy97.73%
ValuesDaily Returns

Aba Chemicals Corp  vs.  Innovative Medical Management

 Performance 
       Timeline  
Aba Chemicals Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aba Chemicals Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Innovative Medical 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Innovative Medical Management are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Innovative Medical may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Aba Chemicals and Innovative Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aba Chemicals and Innovative Medical

The main advantage of trading using opposite Aba Chemicals and Innovative Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aba Chemicals position performs unexpectedly, Innovative Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovative Medical will offset losses from the drop in Innovative Medical's long position.
The idea behind Aba Chemicals Corp and Innovative Medical Management pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Transaction History
View history of all your transactions and understand their impact on performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance